Viking Therapeutics Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +407.3% | -5.9% | +52.2% | +1,266.6% | -6.0% | -9.8% | -17.9% | -20.0% | +118.7% | +146.5% | -21.2% | |
| – | +1,864.8% | -8.1% | +56.4% | +1,282.6% | -6.2% | -9.7% | -17.8% | -20.7% | +119.8% | +147.0% | -21.1% | |
| – | +1.7% | +300.2% | +192.3% | +175.7% | -66.2% | +247.6% | -9.4% | +38.9% | +51.6% | -51.9% | +521.6% | |
| – | +1,766.0% | -6.8% | +56.5% | +1,365.4% | -8.6% | -9.9% | -18.6% | -23.1% | +132.9% | +149.3% | -21.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -46.3% | -92.2% | +5,572.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -73.3% | -3.3% | +33.3% | -47.3% | +56.4% | +70.4% | -27.8% | +164.4% | -13.5% | +39.7% | +173.4% | |
| – | -91.2% | +227.6% | +33.7% | -47.4% | +48.9% | +79.0% | -27.6% | +150.0% | -12.8% | +43.3% | +179.7% | |
| – | +607.1% | +52.0% | +5.5% | – | – | +9.3% | -91.2% | +948.3% | +6.6% | +50.9% | -72.0% | |
| – | -67.6% | +103.2% | +27.0% | -37.3% | +153.5% | +64.0% | -63.8% | +490.7% | -11.9% | +30.6% | +442.7% | |
| – | +70.2% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | -7.8% | +67.4% | +2,111.3% | -6.9% | -11.8% | -17.4% | -28.0% | +139.8% | +152.6% | -27.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.5% | +156.1% | +59.6% | +121.6% | +25.0% | +0.9% | +6.3% | -0.5% | +22.8% | +15.6% | +3.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.